6Shepherd F A,Dancey J, Ramlau R,et al.Prospective randomized trial of doeetaxel versus best supportive care in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy [J].J Clin Oncol,2000, 18(10) :2095-2103.
7Fossella F V,DeVore R,Kerr R N,et al.Randomized phase III tri- al of docetaxel versus vinorelbine or ifosfamide in patients with ad- vanced non-small-cell lung cancer previously treated with platinum- containing chemotherapy regimens:the TAX 320 non-small cell lung cancer study group[J].J Clin Oncol, 2000,18 (12) : 2354-2362.
8Lai C L,Tsai C N,Chiu C H,et al.Phase II randomized trial of triweekly versus days 1 and 8 weekly docetaxel as a second-line treat- ment of advanced non-small cell lung cancer[J].Jpn J Clin Oncol, 2005, 35(12) :700-706.
9Chert Y M,Shih J F,Perng R P,et al.A randomized trial of differ- ent docetaxel schedules in non-small cell lung cancer patients who failed previous platinum -based chemotherapy[J].Chest, 2006, 129 (4) : 1031-1038.
10Belani C P,Dakhil S,Waterhouse D M,et al.Randomized phase II trial of gemeitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer[J].Ann On- col, 2007,18(1) : 110-115.
